Pyrido(2,3-d)pyrimidines useful as HCV inhibitors, and methods for the preparation thereof

Details for Australian Patent Application No. 2006245676 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Lenz, Oliver; Surleraux, Dominique Louis Nestor Ghislain; Raboisson, Pierre Jean-Marie Bernard; Simmen, Kenneth Alan; Lin, Tse-I

Agent Shelston IP

Pub. Number AU-B-2006245676

PCT Pub. Number WO2006/120252

Priority 60/680,405 12.05.05 US; 06075855.4 06.04.06 EP; 05106214.9 07.07.05 EP

Filing date 12 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 2 August 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/120252 Priority application(s): WO2006/120252

2 August 2012 Application Accepted

  Published as AU-B-2006245676

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245680-Communication system and hearing device

2006245675-Pteridines useful as HCV inhibitors and methods for the preparation thereof